Predilife is a leading brand in the field of predictive medicine. They offer a range of comprehensive services and products that help individuals and companies prevent the onset of serious diseases. With their cutting-edge technology and expertise, Predilife's predictive health assessments enable individuals to assess their risk profile for diseases and receive personalized guidance to reduce those risks.

One of their flagship products is the predictive breast cancer assessment, designed exclusively for women. This assessment allows women to determine their risk of developing breast cancer in the next five years and receive tailored recommendations and follow-up care. In addition to breast cancer assessment, Predilife offers a multi-pathology predictive assessment for both men and women.

This assessment evaluates the risk of developing various diseases, including lung cancer, prostate cancer, colorectal cancer, melanoma, and cardiovascular diseases. The medical follow-up is customized based on each individual's risk profile. With a focus on making predictive medicine accessible to all, Predilife aims to empower individuals to take control of their health and prevent serious diseases.

They collaborate with companies, health professionals, and insurance providers to promote personalized and digital predictive medicine, which enhances employee well-being, strengthens the employer brand, and improves overall organizational performance. Predilife's dedication to quality and safety is reflected in their certifications and registrations with regulatory bodies such as the ANSM, FDA, and MHRA. By offering innovative and cost-effective preventive assessments, Predilife is revolutionizing the way we approach healthcare and paving the way towards a healthier future